Letter to the Editor – Response to the recently published joint position statement on best practice recommendations for the care of women experiencing the menopause
Restricted accessResearch articleFirst published online December, 2022
Letter to the Editor – Response to the recently published joint position statement on best practice recommendations for the care of women experiencing the menopause
MikkolaTSSavolainen-PeltonenHTuomikoskiP, et al. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study. Menopause2016; 23(11): 1199–1203. DOI: 10.1097/GME.0000000000000698.
2.
BlumingAZ. Hormone replacement therapy after breast cancer: it is time. Cancer J2022; 28(3): 183–190. PMID: 35594465. DOI: 10.1097/PPO.0000000000000595.
3.
BrewsterAMDoKAThompsonPA, et al.Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol2007; 25(28): 4438–4444. DOI: 10.1200/JCO.2007.10.6815.
4.
KimYJSotoMBraniganGL, et al. Association between menopausal hormone therapy and risk of neurodegenerative diseases: implications for precision hormone therapy. Alzheimers Dement (N Y)2021;7(1):e12174. DOI: 10.1002/trc2.12174.
5.
TraishAGuayATSparkRF. Testosterone therapyin women study group. are the endocrine society's clinical practice guidelines on androgen therapy in women misguided? a commentary. J Sex Med. 2007;4(5):1223-1234; discussion 1234-5. DOI: 10.1111/j.1743-6109.2007.00584.x.
